UBS Maintains a 'Neutral' on Kemet (KEM); Lowers Estimates on Softer Data Points

UBS maintains a 'Neutral' on Kemet (NYSE: KEM), but slashes price target from $16 to $9.50.

UBS analyst says, "Given the leverage in the model (UBSe 50% incr. GM), we foresee FY12/FY13 Revs/EPS of $1b/$1.50, $1b/$1.56 vs. $1.08b/$2.01, $1.12b/$2.12, prev. Our CY12E EPS goes to $1.34 from $2.05 prev. A less severe macro environment, better pricing, and higher restructuring savings from F&E, could yield upside to our estimates. The stock appears cheap on several metrics but earnings visibility is limited."

For more ratings news on Kemet click here and for the rating history of Kemet click here.

Shares of Kemet closed at $8.52 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15
• Reading (RDI) Tops Q2 EPS by 4c